Involuntary Commitment and Forced Psychiatric Drugging in the Trial Courts: Rights Violations as a Matter of Course [PDF]
, 2008 Gottstein, James B. (Jim)
core +1 more source
Lingual Dyskinesia Developing after the First Dose of Methylphenidate Treatment in a Child with Neurodevelopmental Disorders: Genetic Predispositions. [PDF]
Clin Psychopharmacol NeurosciKaragöz D, Kurt HİZ, Şahin N.
europepmc +1 more source
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2007 Tomoyoshi, Kondo, Hiroshi, Ishiguchi
openaire +1 more source
Belly Dancer Dyskinesia: A Case Report and Review of Management. [PDF]
CureusAboukar A, Ibrahim W.
europepmc +1 more source
Impact of Adjunctive Istradefylline on Dyskinesia Onset in Patients with Parkinson's Disease Exhibiting Wearing-Off: An Open-Label Randomized Controlled Trial. [PDF]
Neurol TherTsuboi Y +8 more
europepmc +1 more source
Reporting Frequency of Antipsychotics-Induced Tardive Dyskinesia and Other Extrapyramidal Symptoms: Analysis Based on a Spontaneous Reporting System Database in Japan. [PDF]
Neuropsychopharmacol RepSaga Y, Horio H, Chiang CL, Wakamatsu A.
europepmc +1 more source
Venlafaxine-Associated Takotsubo Cardiomyopathy Complicated by Cardiogenic Shock and Left Ventricular Outflow Tract Obstruction: A Case Report and Literature Review. [PDF]
Acta Cardiol SinWu YJ, Yeh CF, Lin PC, Hung CS.
europepmc +1 more source
A <i>meta</i>-analysis of the long-term efficacy of Amantadine for Levodopa-induced dyskinesia in Parkinson's disease. [PDF]
Clin Park Relat DisordWilliams K +3 more
europepmc +1 more source
Targeting metabotropic glutamate receptors for symptomatic and disease-modifying treatment in Parkinson's disease. [PDF]
NPJ Parkinsons DisAlborghetti M +5 more
europepmc +1 more source
Involvement of Neuroinflammation and Oxidative Stress in L-DOPA-Induced Dyskinesia in Parkinson's Disease: Role of Renin-Angiotensin System and ROCK Pathway. [PDF]
Antioxidants (Basel)Muñoz A +3 more
europepmc +1 more source